STE STERIS plc
STERIS plc provides infection prevention products and services in the United States, Ireland, and internationally. It operates through three segments: Healthcare, Applied Sterilization Technologies, and Life Sciences. The company offers cleaning chemistries and sterility assurance products, automated endoscope reprocessing system and tracking products, endoscopy accessories, instruments, washers, and sterilizers and other pieces of capital equipment, as well as equipment used directly in the procedure rooms, including surgical tables, lights, equipment management services, and connectivity solutions; and various preventive maintenance programs, repair services, custom process improvement consulting, and outsourced instrument sterile processing, as well as instrument, devices, and endoscope repair and maintenance services. It also provides process controls and monitoring systems, as well as integrated sterilization equipment, such as accelerators, product handling, and automation; and sterilization modalities, product development, materials testing, and process validation, as well as support services for sterilization equipment and control systems comprising installation, preventive maintenance, updates, repairs, and troubleshooting. In addition, the company offers pharmaceutical detergents, cleanroom disinfectants and sterilants, pharmaceutical grade and research sterilizers and washers, sterility assurance and maintenance products, vaporized hydrogen peroxide room decontamination systems and sterilizers, and high purity water and pure steam generators; and preventive maintenance programs and repair services to support the operation of capital equipment. It serves healthcare providers, medical device and pharmaceutical manufacturers, biopharmaceutical manufacturing facilities, and hospitals. The company was formerly known as New STERIS Limited and changed its name to STERIS plc in November 2015. STERIS plc was founded in 1985 and is headquartered in Mentor, Ohio.…
Industry Peers
Medical DevicesKey Statistics
About STERIS (NYSE: STE)
›
STERIS (NYSE: STE) is listed on the New York Stock Exchange, where its shares trade in USD. It belongs to the Medical Devices industry, part of the Healthcare sector, and reports about 17,937 employees.
The shares were at 254.76 USD on 19 November 2026, roughly unchanged over 52 weeks. Its 52-week range is 195.14 USD to 269.44 USD: the price is 5.4% below the high and 30.6% above the low.
At a market capitalisation of 24.74B USD, it trades at 30.2 times trailing earnings and 20.5 times forward earnings. The median trailing P/E of its 19 largest Medical Devices peers is 25.4, a premium of 19% for STE. It pays a dividend yielding 1.06% (it pays out 31% of its earnings), against a median of 2.41% among the dividend payers in that peer group.
STERIS reports return on equity of 10.9%, an operating margin of 19.2% and revenue up 8.8% year over year.
Its debt exceeds its cash by 1.52B USD, a debt-to-equity ratio of 0.29. Its Piotroski F-score is 9 out of 9, a strong reading of its financial health. 7 analysts cover the stock, with an average rating of Buy; their mean price target of 281.14 USD is 10.4% above the current price. The next earnings report is expected on 3 February 2027.